Carine Salliot

4.8k total citations · 1 hit paper
63 papers, 2.5k citations indexed

About

Carine Salliot is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Carine Salliot has authored 63 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Rheumatology, 18 papers in Immunology and 14 papers in Hematology. Recurrent topics in Carine Salliot's work include Rheumatoid Arthritis Research and Therapies (29 papers), Spondyloarthritis Studies and Treatments (13 papers) and Autoimmune and Inflammatory Disorders Research (13 papers). Carine Salliot is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (29 papers), Spondyloarthritis Studies and Treatments (13 papers) and Autoimmune and Inflammatory Disorders Research (13 papers). Carine Salliot collaborates with scholars based in France, United States and Canada. Carine Salliot's co-authors include D. van der Heijde, Laure Gossec, M Dougados, Adeline Ruyssen‐Witrand, Sandra Guignard, M. Luc, M. Duclos, Maxime Dougados, Claire Bombardier and Wanruchada Katchamart and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Clinical Infectious Diseases.

In The Last Decade

Carine Salliot

60 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research

2008 487 citations Carine Salliot, D. van der Heijde Annals of the Rheumatic Diseases profile →

Peers

Countries citing papers authored by Carine Salliot

Since Specialization

Citations

This map shows the geographic impact of Carine Salliot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carine Salliot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carine Salliot more than expected).

Fields of papers citing papers by Carine Salliot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carine Salliot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carine Salliot. The network helps show where Carine Salliot may publish in the future.

Co-authorship network of co-authors of Carine Salliot

This figure shows the co-authorship network connecting the top 25 collaborators of Carine Salliot. A scholar is included among the top collaborators of Carine Salliot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carine Salliot. Carine Salliot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE Study 2024 ·Drugs - Real World Outcomes ·Bruno Fautrel, Yoram Bouhnik, Carine Salliot, Franck Carbonnel, Mathurin Fuméry, (unknown), Yves Maugars, Mathurin Flamant, Fabienne Coury, (unknown), (unknown), Janet Addison, (unknown)	0
2	Distinct Pathophysiologic Pathways Support Stratification of Sjögren's Disease Based on Symptoms, Clinical, and Routine Biological Data 2024 ·Arthritis & Rheumatology ·Yann Nguyen, Maxime Beydon, Jacques‐Eric Gottenberg, Jacques Morel, Aleth Perdriger, Emmanuelle Dernis, Divi Cornec, Valérie Devauchelle‐Pensec, D. Sène, Philippe Dieudé, Marion Couderc, A.L. Fauchais, C. Larroche, Olivier Vittecoq, Carine Salliot, É. Hachulla, Véronique Le Guern, Xavier Mariette, Raphaèle Séror, Gaëtane Nocturne	1
3	Lifetime female hormonal exposure and risk of rheumatoid arthritis in postmenopausal women: Results from the French E3N cohort 2022 ·Joint Bone Spine ·Carine Salliot, Yann Nguyen, (unknown), Xavier Mariette, Marie‐Christine Boutron‐Ruault, Raphaèle Séror	7
4	Improving accuracy of self-reported diagnoses of rheumatoid arthritis in the French prospective E3N-EPIC cohort: a validation study 2019 ·BMJ Open ·Yann Nguyen, Carine Salliot, Gaëlle Gusto, Elise Descamps, Xavier Mariette, Marie‐Christine Boutron‐Ruault, Raphaèle Séror	17
5	Drug maintenance of a second tumor necrosis factor alpha inhibitor in spondyloarthritis patients: A real-life multicenter study 2019 ·Joint Bone Spine ·(unknown), (unknown), (unknown), Philippe Goupille, Carine Salliot	6
6	Application of Recommendations Regarding the Use of Subcutaneous Tumor Necrosis Factor Inhibitors in Spondyloarthritis by Rheumatologists in Daily Practice 2018 ·The Journal of Rheumatology ·(unknown), (unknown), (unknown), (unknown), Philippe Goupille, Carine Salliot	2
7	Type I cryoglobulinemia in multiple myeloma, a rare entity: analysis of clinical and biological characteristics of seven cases and review of the literature 2012 ·Leukemia & lymphoma ·Judith Payet, (unknown), Niloufar Kavian, Olivia Chandesris, N. Dupin, (unknown), Alexandre Karras, Carine Salliot, Felipe Suárez, Hervé Avet‐Loiseau, (unknown), (unknown), Sophie Park, Jérôme Tamburini, C. Roux, Didier Bouscary, L. Sparsa	30
8	Factors Associated with Severe Skin Infections in Patients Treated with Biologic Therapies for Inflammatory Rheumatic Diseases 2012 ·Dermatology ·(unknown), David Farhi, A. Lebrun, Carine Salliot, Maxime Dougados, N. Dupin	3
9	PTPN22 R620W genotype-phenotype correlation analysis and gene-environment interaction study in early rheumatoid arthritis: results from the ESPOIR cohort 2011 ·Lara D. Veeken ·Carine Salliot, (unknown), Cédric Lukas, Mickaël Guedj, Caroline Paccard, Joëlle Bénessiano, Maxime Dougados, Pascale Nicaise, Olivier Meyer, Philippe Dieudé	15
10	Effect of biotherapies on fatigue in rheumatoid arthritis: a systematic review of the literature and meta-analysis 2011 ·Lara D. Veeken ·(unknown), Carine Salliot, Francis Bérenbaum, Jérémie Sellam	84
11	Predictors for remission in rheumatoid arthritis patients: A systematic review 2010 ·Arthritis Care & Research ·Wanruchada Katchamart, Sindhu R. Johnson, Huan Lin, (unknown), Carine Salliot, Claire Bombardier	124
12	Hormonal replacement therapy may reduce the risk for RA in women with early arthritis who carry HLA-DRB1 01 and/or 04 alleles by protecting against the production of anti-CCP: results from the ESPOIR cohort 2009 ·Annals of the Rheumatic Diseases ·Carine Salliot, Claire Bombardier, (unknown), (unknown), Maxime Dougados	29
13	Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research breakdown → 2008 ·Annals of the Rheumatic Diseases ·Carine Salliot, D. van der Heijde	487
14	Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials 2008 ·Annals of the Rheumatic Diseases ·Carine Salliot, M Dougados, Laure Gossec	356
15	Arthritis Due toMycobacterium xenopi:A Retrospective Study of 7 Cases in France 2006 ·Clinical Infectious Diseases ·Carine Salliot, Nicole Desplaces, Philippe Boisrenoult, (unknown), Philippe Beaufils, Véronique Vincent, Patrick Mamoudy, (unknown)	10
16	Panton-Valentine leukocidin-producing Staphylococcus aureus infections: Report of 4 French cases 2006 ·Scandinavian Journal of Infectious Diseases ·Carine Salliot, Valérie Zeller, Xavier Puéchal, V. Manceron, Stéphane Sire, (unknown), Jérôme Étienne, Nicole Desplaces, Jean-Marc Ziza	23
17	Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study 2006 ·Annals of the Rheumatic Diseases ·Sandra Guignard, Laure Gossec, Carine Salliot, Adeline Ruyssen‐Witrand, M. Luc, M. Duclos, Maxime Dougados	163
18	Infections during tumour necrosis factor- blocker therapy for rheumatic diseases in daily practice: a systematic retrospective study of 709 patients 2006 ·Lara D. Veeken ·Carine Salliot, Laure Gossec, Adeline Ruyssen‐Witrand, M. Luc, M. Duclos, Sandra Guignard, Maxime Dougados	117
19	Sjogren's syndrome is associated with and not secondary to systemic sclerosis 2006 ·Lara D. Veeken ·Carine Salliot, Luc Mouthon, (unknown), Jean Sibilia, Loı̈c Guillevin, J.E. Gottenberg, Xavier Mariette	58
20	Disseminated extrapulmonary tuberculosis revealed by humeral osteomyelitis with chronic unremarkable pain 2004 ·Joint Bone Spine ·Carine Salliot, Yannick Allanore, A Lebrun, H. Guérini, K. Champion, Philippe Anract, André Kahan	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact